What types of seizures are relevant in a patient with a history of severe depression and psychotic symptoms, particularly those being treated with medications such as clozapine (clozapine) that can lower the seizure threshold?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 6, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Types of Seizures in Patients on Clozapine

In patients with severe depression and psychotic symptoms treated with clozapine, you must monitor for generalized tonic-clonic seizures, which occur in a dose-dependent manner at rates of 1% at low doses (<300 mg/day), 2.7% at medium doses (300-600 mg/day), and 4.4% at high doses (≥600 mg/day), with cumulative risk reaching 10% after 3.8 years of treatment. 1, 2

Primary Seizure Type Associated with Clozapine

Generalized tonic-clonic seizures are the predominant seizure type reported with clozapine treatment 2. These are the classic "grand mal" seizures involving:

  • Loss of consciousness
  • Tonic phase (muscle rigidity)
  • Clonic phase (rhythmic jerking movements)
  • Postictal confusion and fatigue

The FDA explicitly warns that seizures have occurred with clozapine treatment and the risk is dose-related 1.

Dose-Dependent Seizure Risk Stratification

The seizure risk follows a clear dose-response relationship 2, 3:

  • Low dose (<300 mg/day): 1.0% seizure risk 2
  • Medium dose (300-600 mg/day): 2.7% seizure risk 2
  • High dose (≥600 mg/day): 4.4% seizure risk 2
  • Cumulative risk: 10% after 3.8 years of continuous treatment 2

Rapid upward titration increases seizure risk independent of final dose 2, 3.

Other Seizure Types in Psychiatric Contexts

While clozapine primarily causes generalized tonic-clonic seizures, patients with psychiatric illness and comorbid neurological conditions may experience 4:

  • Focal seizures with preserved awareness (formerly "simple partial") 4
  • Focal seizures with impaired awareness (formerly "complex partial") 4
  • Typical or atypical absence seizures 4
  • Myoclonic seizures 4
  • Atonic, clonic, and tonic seizures (rare) 4

Critical Risk Factors Beyond Clozapine Dose

Additional seizurogenic conditions that compound clozapine's effects include 1, 3:

  • History of epilepsy or prior seizures
  • CNS pathology or structural brain lesions
  • Concurrent medications that lower seizure threshold
  • Alcohol abuse or withdrawal
  • Rapid dose escalation during titration 2
  • Metabolic disturbances (hypocalcemia, hypomagnesemia) 4

Acute Symptomatic vs. Epilepsy Distinction

A critical distinction exists between acute symptomatic seizures and epilepsy 5:

  • Acute symptomatic seizures are provoked by immediate precipitants (medication initiation, metabolic derangement, intoxication) and do not represent ongoing epilepsy 5
  • Epilepsy represents recurrent unprovoked seizures requiring long-term management 5

This distinction is crucial because clozapine can still be initiated in patients with a history of acute symptomatic seizures using appropriate precautions 5.

Management Strategy for Clozapine-Related Seizures

Thirty-one of 41 patients (76%) with clozapine-related seizures were successfully continued on clozapine through either dose reduction or addition of anticonvulsant medication 2. The recommended approach includes 5, 6:

Prophylactic Anticonvulsant Therapy

  • Strongly consider prophylactic lamotrigine or valproic acid before starting clozapine in patients with recent seizure history 5
  • Valproic acid is specifically recommended for prophylaxis and management of clozapine-related seizures based on side effect profile 6
  • Avoid carbamazepine as it lowers blood cell counts and is contraindicated with clozapine 5

Titration Protocol

  • Start at 12.5 mg once or twice daily 1, 5
  • Increase by no more than 25 mg increments once or twice per week 5
  • Use divided dosing to minimize peak plasma levels 1
  • Target therapeutic plasma levels of 350-550 ng/mL once stable 5

Seizure Monitoring During Treatment

The FDA mandates that clinicians 1:

  • Initiate treatment at 12.5 mg to minimize seizure risk
  • Titrate slowly with divided dosing
  • Use caution in patients with seizure history or predisposing factors
  • Warn patients about engaging in activities where sudden loss of consciousness could cause serious harm (driving, operating machinery, swimming)

Common Pitfall to Avoid

Do not assume all seizures in psychiatric patients are medication-related. Secondary causes of seizures in patients with psychosis include 4:

  • Infections (meningitis, encephalitis)
  • Metabolic derangements (hypoglycemia, hyponatremia, hypocalcemia)
  • Structural brain lesions (tumors, stroke)
  • Substance intoxication or withdrawal
  • Autoimmune encephalitis

A thorough evaluation including neuroimaging and EEG may be warranted for new-onset seizures, particularly if atypical features are present 4.

References

Research

Clozapine-related seizures.

Neurology, 1991

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Initiating Clozapine in Patients with Acute Symptomatic Seizure

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Clozapine and seizures: a review.

Canadian journal of psychiatry. Revue canadienne de psychiatrie, 1994

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.